ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KNWN Know Labs Inc (QB)

2.53
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Know Labs Inc (QB) USOTC:KNWN OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.53 2.52 2.66 0.00 01:00:00

Current Report Filing (8-k)

18/07/2017 9:16pm

Edgar (US Regulatory)




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report: July 14, 2017


    VISUALANT, INCORPORATED    

(Exact name of Registrant as specified in its charter)


    Nevada    

    000-30262    

    90-0273142    

(State or jurisdiction of incorporation)

(Commission File No.)

(IRS Employer Identification No.)


500 Union Street, Suite 810

Seattle, Washington 98101

                (206) 903-1351                

(Address of Registrant’s principal executive office and telephone number)




Section 1 - Registrant’s Business and Operations


Item 1.01.  Entry into a Material Definitive Agreement.


On July 14, 2017, Visualant, Incorporated (the “Company”) entered into amendments to two demand promissory notes, totaling $600,000, and a note payable for $200,000 related to the Umpqua Bank Business Loan Agreement with Mr. Erickson, our Chief Executive Officer and/or entities in which Mr. Erickson has a beneficial interest. The amendments extend the due date from March 31, 2017 to September 30, 2017 and continue to provide for interest of 3% per annum and a second lien on company assets if not repaid by September 30, 2017 or converted into convertible debentures or equity on terms acceptable to the Holder.


The foregoing description of the Amendment 10 to Demand Promissory Note, Amendment 11 to Demand Promissory Note and Amendment 12 to Demand Promissory Note is qualified in its entirety by reference to the Amendments attached to this Current Report on Form 8-K as Exhibits 10.1, 10.2 and 10.3 are incorporated by reference into this 1.01.


Item 9.01 Financial Statements and Exhibits.


(d)     Exhibits –


Exhibit No.

Description

 

 

10.1

Amendment 10 to Demand Promissory Note dated July 14, 2017 by and between Visualant, Incorporated and J3E2A2Z LP.

 

 

10.2

Amendment 11 to Demand Promissory Note dated July 14, 2017 by and between Visualant, Incorporated and J3E2A2Z LP.

 

 

10.3

Amendment 12 to Demand Promissory Note dated July 14, 2017 by and between Visualant, Incorporated and J3E2A2Z LP.



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Registrant: VISUALANT, INCORPORATED

 

 

 

 

By:

/s/ Ronald P. Erickson

 

 

Ronald P. Erickson, CEO


July 18, 2017


- 2 -


1 Year Know Labs (QB) Chart

1 Year Know Labs (QB) Chart

1 Month Know Labs (QB) Chart

1 Month Know Labs (QB) Chart